Biosynthesis of the psychotropic plant diterpene salvinorin A: Discovery and characterization of the Salvia divinorum clerodienyl diphosphate synthase

Pelot, K. A., Mitchell, R., Kwon, M., Hagelthorn, D. M., Wardman, J. F., Chiang, A., ... & Zerbe, P. | The Plant Journal | 19 November 2016

Chemogenomics knowledgebase and systems pharmacology for hallucinogen target identification-Salvinorin A as a case study

Xu, X. | Doctoral dissertation, University of Pittsburgh | 8 August 2016

Clinical Applications of Hallucinogens: A Review

Garcia-Romeu, A., Kersgaard, B., & Addy, P. H. | Experimental and clinical psychopharmacology | 1 July 2016

Salvia divinorum: toxicological aspects and analysis in human biological specimens

Margalho, C., Corte-Real, F., López-Rivadulla, M., & Gallardo, E. | Bioanalysis | 9 June 2016

“Quite a Profoundly Strange Experience”: An Analysis of the Experiences of Salvia divinorum Users

Hutton, F., Kivell, B., & Boyle, O. | Journal of Psychoactive Drugs | 13 May 2016

Depressant Effects of Salvia divinorum Involve Disruption of Physiological Sleep

González‐Trujano, M. E., Brindis, F., López‐Ruiz, E., Ramírez‐Salado, I., Martínez, A., & Pellicer, F. | Phytotherapy Research | 1 April 2016

Time course of pharmacokinetic and hormonal effects of inhaled high-dose salvinorin A in humans.

Johnson, M. W., MacLean, K. A., Caspers, M. J., Prisinzano, T. E., & Griffiths, R. R. | Journal of psychopharmacology (Oxford, England) | 15 February 2016

Naltrexone but not ketanserin antagonizes the subjective, cardiovascular and neuroendocrine effects of salvinorin-A in humans

Maqueda, A. E., Valle, M., Addy, P. H., Antonijoan, R. M., Puntes, M., Coimbra, J., ... & Barker, S. | International Journal of Neuropsychopharmacology | 12 Februari 2016

Salvia divinorum: An overview of the usage, misuse, and addiction processes

Mahendran, R., Lim, H. A., Tan, J., Chua, S. M., & Winslow, M. | Asia‐Pacific Psychiatry | 29 November 2015

Plant and Fungal Hallucinogens as Toxic and Therapeutic Agents

Carlini, E. A., & Maia, L. O. | 9 November 2015

Kappa Opioids, Salvinorin A and Major Depressive Disorder

T Taylor and Francesca Manzella | Current Neuropharmacology | 1 October 2015

[Psychedelics and quasi-psychedelics in the light of contemporary research: medical cannabis, MDMA, salvinorin A, ibogaine and ayahuasca]

Szabo, A., Kazai, A., Frecska, E., & Brys, Z. | official journal of the Hungarian Association of Psychopharmacology | 17 September 2015

Salvinorin A, a kappa-opioid receptor (KOP-r) agonist hallucinogen: Pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders

Butelman, E., & Kreek, M. J. | Frontiers in Pharmacology | 08 Sep 2015

Salvinorin-A induces intense dissociative effects, blocking external sensory perception and modulating interoception and sense of body ownership in humans

Maqueda, A. E., Valle, M., Addy, P. H., Antonijoan, R. M., Puntes, M., Coimbra, J., ... & Riba, J. | International Journal of Neuropsychopharmacology | 5 June 2015

The subjective experience of acute, experimentally-induced Salvia divinorum inebriation

Addy, P. H., Garcia-Romeu, A., Metzger, M., & Wade, J. | Journal of Psychopharmacology | 17 February 2015

Drug models of schizophrenia

Steeds, H., Carhart-Harris, R. L., & Stone, J. M. | Therapeutic Advances in Psychopharmacology | 5 February 2015

Editorial (Thematic Issue: Introduction to ‘Beneficial Effects of Psychedelics with a Special Focus on Addictions’)

Kortekaas, R., & Breeksema, J. J. | Current Drug Abuse Reviews | 28 January 2015

Salvinorin A and Related Compounds as Therapeutic Drugs for Psychostimulant-Related Disorders

dos Santos, R. G., Crippa, J. A., Machado-de-Sousa, J. P., & Hallak, J. E. | Current Drug Abuse Reviews | 28 January 2015

Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues

Riley, A. P., Groer, C. E., Young, D., Ewald, A. W., Kivell, B. M., & Prisinzano, T. E. | Journal of medicinal chemistry | 26 December 2014

Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor

Polepally, P. R., Setola, V., Vardy, E., Roth, B. L., Mosier, P. D., & Zjawiony, J. | Planta Medica | 6 October 2014

Does the Nervous System Have an Intrinsic Archaic Language? Entoptic Images and Phosphenes

Sayin, H. U. | Neuroquantology | 2 August 2014

The Consumption of Psychoactive Plants in Ancient Global and Anatolian Cultures During Religious Rituals: The Roots of the Eruption of Mythological Figures and Common Symbols in Religions and Myths

Sayin, H. U. | NeuroQuantology | 12 June 2014

The induction of synaesthesia with chemical agents: a systematic review

Luke, D. P., & Terhune, D. B. | Frontiers in Psychology | 17 October 2013

Effects of Schedule I drug laws on neuroscience research and treatment innovation

Nutt, D. J., King, L. A., & Nichols, D. E.| Nature Reviews Neuroscience | 12 June 2013

Hallucinogen persisting perception disorder: what do we know after 50 years?

Halpern, J. H., & Harrison, G. P. Jr. | Drug and Alcohol Dependence | 1 March 2013